Use of sintilimab in primary adenosquamous carcinoma of the liver results in pathological complete response: a case report and literature review
Adenosquamous cell carcinoma (ASC) is a rare and aggressive malignant tumor which consists of both adenocarcinoma (AC) and squamous cell carcinoma (SCC) component types. Although ASC can sometimes develop in the stomach, pancreas, gallbladder and thyroid, it rarely occurs in the liver. As such, prim...
Saved in:
| Main Authors: | Zhiqing Bai, Yu-Ann Chen, Ying Xiao, Jianping Song, Jianwei Song, Canhong Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1578368/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer
by: Peipei Mou, et al.
Published: (2025-04-01) -
Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China
by: Lei Mao, et al.
Published: (2025-06-01) -
Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
by: Ming-xing Wang, et al.
Published: (2025-01-01) -
Unveiling cutaneous adenosquamous carcinoma: A systematic review and case analysis of a rare cutaneous malignancy
by: Adam Christie, et al.
Published: (2025-01-01) -
Stevens–Johnson syndrome induced by Sintilimab: a case report and literature review
by: Huan Kuang, et al.
Published: (2025-05-01)